Methenamine Hippurate Orion

Methenamine Hippurate, the active ingredient in Methenamine Hippurate Orion, is a urinary antiseptic presented as an oral tablet for oral use. It is employed to help prevent recurrent urinary tract infections and may be used as an adjunct in uncomplicated urinary infections.

GNH USA supplies Methenamine Hippurate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methenamine Hippurate is used in the urinary tract infection pathway to reduce bacterial growth.

- Prevention of recurrent urinary tract infections: helps lower the frequency of infections by maintaining an acidic urinary environment that limits bacterial proliferation. - Adjunctive treatment of uncomplicated urinary tract infections: used together with appropriate antibiotics to enhance bacterial eradication in acidic urine.

Methenamine Hippurate may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Dyspepsia: discomfort or pain in the upper abdomen. - Abdominal pain: cramping or tenderness. - Headache: transient head discomfort. - Metallic taste: altered taste sensation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash. - Hematuria: presence of blood in urine. - Renal impairment: reduced kidney function. - Hepatic dysfunction: abnormal liver enzymes. - Stevens‑Johnson syndrome: severe skin reaction. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

Before prescribing methenamine hippurate, consider the following safety measures. - Assess renal function: ensure adequate kidney function before initiating therapy. - Monitor urinary pH: effectiveness requires acidic urine (pH < 6). - Avoid in severe liver disease: hepatic impairment may affect drug metabolism. - Use caution in pregnancy: safety has not been established. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Methenamine hippurate can interact with other medicines that alter urinary pH or renal handling.

Major Interactions (Avoid): - Alkalinizing agents (e.g., sodium bicarbonate): raise urinary pH, reducing drug activation. - Antacids containing magnesium or aluminum: increase urinary pH, decreasing efficacy. - Probenecid: may increase systemic methenamine levels.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: additive risk of nephrotoxicity. - Loop diuretics: may change urinary concentration and affect drug activity.